In-Silico Approach Based Identification of Potential Bioactive Compounds from Phytochemicals as Inhibitors of Hbv- Mediated Hepatocellular Carcinoma

In-Silico Approach Based Identification of Potential Bioactive Compounds from Phytochemicals as Inhibitors of Hbv- Mediated Hepatocellular Carcinoma P.R.Kiresee Saghana Assistant Professor Department of Bioinformatics, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai-600117, Tamil Nadu, India. S. Shanmugavani Assistant Professor Department of Bioinformatics, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai-600117, Tamil Nadu, India. R. Priya Assistant Professor Department of Bioinformatics, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai-600117, Tamil Nadu, India. P. Amudha Assistant Professor Department of Biochemistry, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai - 600117, Tamil Nadu, India. V. Dhivya Assistant Professor Department of Civil Engineering, Vels Institute of Science and Technology in Advanced Studies (VISTAS), Pallavaram, Chennai-600117, Tamil Nadu, India.

Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, representing approximately 90% of all liver cancer cases and is the second leading cause of cancer-related deaths. Hepatitis B virus (HBV) infection is the primary risk factor for HCC, responsible for about 70-80% of HCC cases in India and around 55% worldwide. This study aims to identify bioactive compounds that can counteract Hepatitis B infection. The human hepatitis B capsid protein (1QGT), a key protein involved in the malignant transformation process, was selected for virtual screening with various phytochemical compounds from different plants. Following virtual screening and pharmacokinetic analysis using Swiss ADME and admetSAR, 16 compounds were shortlisted and docked with the target protein using AutoDock Vina. The docking results were compared to Tenofovir. The analysis indicated that the compounds 4,7-Methanofuro[3,2-c] oxacycloundecin-6(4H) one (-8.7kcal/mol) and Luvangetin (-8.1kcal/mol) are potential inhibitors of the Human Hepatitis B viral capsid protein.
03 16 2026 03 18 2026 1357 10.52711/0974-360X.2026.00195 https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-3-56 REFERENCES: 10.1016/j.jceh.2014.05.013 1. Acharya SK. Epidemiology of hepatocellular carcinoma in India. J Clin Exp Hepatol. 2014; 4(Suppl 3): S27–S33. 10.1111/brv.12415 2. Albuquerque TAF, Drummond do Val L, Doherty A. From humans to hydra: Patterns of cancer across the tree of life. Biol Rev Camb Philos Soc. 2018; 93:1715-1734 10.1002/pca.2936 3. Alcazar MA, Wright K, Vaswani A, Caruso, M, Reed RL, Bailey CF, Maier, CS. Integration of mass spectral fingerprinting analysis with precursor ion (MS1) quantification for the characterization of botanical extracts: application to extracts of Centella asiatica (L.) Urban. Phytochem Anal. 2020; 1-17. 4. Andrea Marengo, Chiara Rosso, and Elisabetta Bugianesi. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. ARI. 2015; 14: 14:13. 10.1002/ptr.6934 5. Anshid Venthodika, Navnidhi Chhikara, Sandeep Mann, Mukesh Kumar Garg, Sajad Ahmad Sofi, Anil Panghal. Bioactive compounds of Aegle marmelos L., medicinal values and its food applications: A critical review, John Wiley & Sons Ltd. 2020: 1–21. 10.1155/2014/898502 6. Bajpai V. The challenges confronting public hospitals in India, their origins, and possible solutions. Adv Public Health. 2014; 2014: 898502. 10.1155/2021/6658776 7. Bo J, Li S, Ma P, Zhu Y, Zhang Y. Research on early warning mechanism and model of liver cancer rehabilitation based on CSSVM Hindawi. J Healthc Eng. 2021. 10.3322/caac.21492 8. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. 10.3390/ijms222413651 9. Caroline Lefeuvre, Hélène Le Guillou-Guillemette and Alexandra Ducancelle. A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis, International Journal of Molecular Sciences. 2021) 10.1158/1055-9965.EPI-11-0643 10. Center MM, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2011; 20(11): 2362–8. 11. P.R. Kiresee Saghana and S. Hemalatha.Potential of 4-Hydroxypropiophenone against Matrix Metalloproteinase 10: An In-silico docking study. Int. J. Adv. Res. Biol. Sci. 2016) 3(4): 8-12 10.3390/cancers15020533 12. Chen Shen, Xin Jiang, Mei Li and Yao Luo. Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances, Cancers. 2023; 15: 533. 10.7759/cureus.19274 13. Cyriac A. Philips, Sasidharan Rajesh, Dinu C. Nair, Rizwan Ahamed, Jinsha K. Abduljaleel, Philip Augustine. Hepatocellular Carcinoma in 2021: An Exhaustive Update, Cureus 2021; 13(11): e19274. 10.5958/0974-4150.2017.00132.8 14. Tanveer Hasan, Raza Murad Ghalib, Sayed Hasan Mehdi, P. K. Singh, S. S. R. Baqri. Normal Mode Analysis, Electronic Parameters and molecular docking study of 3, 5, 4’-Trihydroxy-6, 7-Dimethoxy-Flavone (Eupalitin) using First Principle. Asian J. Research Chem. 2017; 10(6): 789-797. 10.5958/0974-4150.2019.00054.3 15. Mohmedyasin F. Mansuri, Shravan B. Rathod. Förster Resonance Energy Transfer Investigation between PPO and Coumarin 151 Dyes and Docking studies with Prolyl-tRNA Synthetase Conformers. Asian J. Research Chem. 2019; 12(6): 295-302. 10.5958/0974-4150.2020.00012.7 16. Samir Zeroual, Ismail Daoud, Randa Gaouaoui, Said Ghalem. In vitro and Molecular Docking Studies of DPPH with Phoenix dactylifera L. (Deglet-Nour) Crude Fruits extracts and Evaluation of their Antioxidant Activity; Asian J. Research Chem. 2020; 13(1): 52-59. 17. Sindhu. T. J, Akhilesh K. J, Anju. Jose, Binsiya K. P, Blessy Thomas, Elizabeth Wilson. Antibacterial Screening of Clerodendrum infortunatum leaves: Experimental and Molecular docking studies. 10.52711/0974-4150.2023.00062 18. Uzma Khan, Souvik Sur. Exploring DNA Binding of Benzothiazole-based Known Drugs: A Molecular Docking Investigation. Asian Journal of Research in Chemistry. 2023; 16(5): 383-8. 10.52711/0974-4150.2024.00004 19. Sathish Kumar Mittapalli, J N Narendra Sharath Chandra, Jay Prakash Soni, Ram Babu Tripathi, Iffath Rizwana. Virtual Screening and Pharmacophore Modeling for discovery of Biologically Active Natural Products as Inhibitors of Odorant-binding Proteins. Asian Journal of Research in Chemistry. 2024; 17(1): 17-4. 10.5958/0975-4377.2020.00008.7 20. Amol Pawar, Chetan Salunke, Kailaspati Chittam, Anita B. Patil. Development of an Analytical Method of Glycyrrhizin by using High Pressure Liquid Chromatography. Res. J. Pharma. Dosage Forms and Tech.2020; 12(2): 49-52. 10.5958/2321-5836.2018.00002.2 21. Sudhakar P, Poorana Pushkalai S, Sabarinath C, Priyadharshini S, Haripriya S . Molecular docking and synthesis of 1, 2, 4 - triazin analogue of diclofenac as potential ligand for parkinson’s. Res. J. Pharmacology and Pharmacodynamics.2018; 10(1): 08-12. 10.5958/0974-360X.2017.00053.1 22. Mohamed Zerein Fathima, T.S. Shanmugarajan, S. Satheesh Kumar, B.V.Venkata Nagarjuna Yadav. Comparative in Silico Docking Studies of Hinokitiol with Sorafenib and Nilotinib against Proto-Oncogene Tyrosine-Protein Kinase(ABL1) and Mitogen-activated Protein Kinase (MAPK) to Target Hepatocellular Carcinoma. Research J. Pharm. and Tech. 2017; 10(1): 257-262. 10.5958/0974-360X.2017.00515.7 23. Jeyabaskar Suganya, Viswanathan T, Mahendran Radha, Nishandhini Marimuthu. In silico Molecular Docking studies to investigate interactions of natural Camptothecin molecule with diabetic enzymes. Research J. Pharm. and Tech. 2017; 10(9): 2917-2922.